4Hsu HM, Lu CF, Lee SC, et al. Seroepidemiology surey for hepatitis B virus infection in Taiwan: the effect of hepatitis B mass immuination. J Infect Dis, 1999,179:367-370.
5WHO.Hepatitis B surface antigen assay: operational characteristics.2000.1-15.
6Norihiro F,Jun H,Yasunori S.The elimination Of hepatitis B virus infection:changing seroepidemiology of hepatitis A and B virus infection in Okinawa Japan over a 26-year period Am J Med Hyp,1998.59:693—698.
9Liaw YF, Leung N, Guan R,et al. Asian-Pacific consensus statement on the management of chronic hepatitis B: an update[J]. J Gastroenterol Hepatol,2003,18(3): 239-245.
10Schalm SW, Heathcote J, Cianciara J,et al. Lamivudine and alpha interferon combination treatment of patients with chronic hepatitis B infection: a randomised trial[J]. Gut,2000,46(4): 562-568.
